RESULTS OF THE SCREENING PROGRAM OF BREAST AND CERVICAL CANCERS OF THE CANCER EARLY DIAGNOSIS, SCREENING AND TRAINING CENTER
Abstract
Breast and cervical cancers, among the most common cancers in women, are included within the scope of the screening program in Cancer Early Diagnosis, Screening, and Training Center (KETEM). The aim of this study was to retrospectively evaluate the applications made for breast and cervical cancer screening, examinations, and anamnesis forms taken in this direction during the 2016, 2017 years. In this cross-sectional retrospective study, 632 applications made to Elazığ KETEM for breast and cervical cancer screening were evaluated. SPSS 22.0 program was used in data analysis. Kolmogrov-Smirnov test was used to investigate whether the data were normally distributed. Mann-Whitney U and Chi-square tests were used for statistical evaluations and p<0.05 was accepted as statistical significance. The median age of participants was 50 (min:40, max:66). Cervical precancerous lesions were found in the smear test of 17 people. Mammography results revealed that 42.6% of the participants had BI-RADS 1, 2, and 3. As a result of further examinations and biopsy, 17 (2.7%) of 25 participants with BI-RADS 4, 5 were found to have breast cancer. The results obtained as a result of the screening were not found to be related to the socio-demographic characteristics of the participants. Screening tests play an important role in the early diagnosis of cancer, decreasing mortality and morbidity. Mammography and Pap smear tests are inexpensive, easily applicable, easily accessible, and affordable screening tests. Therefore, the promotion of these screening programs should be increased and the public should be encouraged to participate in these programs.
Keywords
References
- 1. Fahad Ullah M. Breast cancer: current perspectives on the disease status. Adv Exp Med Biol. 2019;1152:51-64.
- 2. Villarreal-Garza C, Aguila C, Magallanes-Hoyos MC, Mohar A, et al. Breast cancer in young women in Latin America: an unmet, growing burden. Oncologist. 2013;18(12):1298-306.
- 3. Coughlin SS. Epidemiology of breast cancer in women. Adv Exp Med Biol. 2019;1152:9-29.
- 4. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010. A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60:99-119.
- 5. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
- 6. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005;89(2):4-12.
- 7. Aydın F, Tuncer ZS. Servikovaginal sitoloji ile önemi belirlenemeyen atipik skuamöz hücreler (ASCUS) ve önemi belirlenemeyen atipik glandüler hücreler (AGUS) tanısı alan olguların değerlendirmesi. T Klin Jinekol Obst. 2002;12:148-54.
- 8. Thomas C, Apgar MD. The 2001 Bethesda system terminology. Journal of the J Am Aced of Fam Phy. 2003;68:1-9.
- 9. Smith JHF. Bethesda. Cytopathology. 2001;13:4-10.
- 10. Ulusal Serviks (Rahimağzı) Kanseri Tarama Standartları. Available from: https://elazigism.saglik.gov.tr/TR,27216/ketem.html. ET: 24.05.2021.
- 11. American College of Radiology (ACR). Breast Imaging Reporting and Data System (BI–RADS). 4th ed. Reston: American College of Radiology. 2003:135-8.
- 12. D’Orsi CJ, Newell MS. BI–RADS decoded: detailed guidance on potentially confusing issues. Radiol Clin North Am. 2007;45(5):751–63.
- 13. Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda System terminology. Am Fam Physician. 2003;68(10):1992-8.
- 14. Berek JS. Simplification of the new Bethesda 2001 classification system. Am J Obstet Gynecol. 2003;188(3):2-5.
- 15. Astım, E. Cost-Effectiveness analysis of a prospective breast cancer screening program in Turkey. In partial fulfıllment of the requirements for the degree of master of science in economics in the department of economics. METU. January 2011:63-8.
- 16. Taş, ME (editör). Kanser Erken Tanısı ve KETEM Projesi Sonuç Raporu. Burak Ofset. 2012: 25-33.
- 17. Derici H, Tansuğ T, Nazlı O, Bozdağ AD, Koç O, Varer M, Yiğit S. Nonpalpabl meme lezyonlarının stereotaktik işaretlenmesi ve cerrahi eksizyonu. Meme Sağlığı Dergisi. 2007;3(1):10-13.
- 18. Anderson BO, Yip CH, Ramsey SD, Bengoa R, Braun S, Fitch M, et al. Breast cancer in limited-resource countries: health care systems and public policy. The Breast Journal. 2006;12(1): 54-69.
- 19. Parkin DM, Fernandez LMG. Use of statistics to assess the global burden of breast cancer. The Breast Journal. 2006;12(1):70-80.
- 20. Şahin S. Kanserde erken tanı ve tarama programları. Ege Tıp Dergisi. 2015;54(EkSayı):41-5.
- 21. Smith RA, Caleffi M, Albert US, Chen TH, Duffy SW, Franceschi D, et al. Breast cancer in limited-resource countries: Early detection and ccess to care. The Breast Journal. 2006;12(1):16-26.
- 22. Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A, et al. Guideline implementation for breast healthcare in lowincome and middle-income countries. Overview of the breast health global initiative global summit 2007. Cancer Supplement. 2008;113(8):2221-43.
- 23. Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiology. 2009;33:315-8.
- 24. Anderson BO, Braun S, Carlson RW, Gralow JR, Lagios MD, Lehman C, et al. Overview of breast health care guidelines for countries with limited resources. The Breast Journal. 2003;9(2):42-50.
- 25. Güner H. Jinekolojik Onkoloji Meme Hastalıkları. Güner H (Ed). 3. Basım. Çağdaş Medikal Kitapevi ve Yayıncılık Hizmetleri. Ankara. 2002:297-313.
- 26. Kurdoğlu Z, Kurdoğlu M, Kundakçı Gelir G, Keremoğlu Ö. Van Kanser Erken Teşhis, Tarama ve Eğitim Merkezi’ne ait serviks ve meme kanserlerini tarama programı sonuçları. Van Tıp Dergisi. 2009;16(4):119-23.
KANSER ERKEN TEŞHİS, TARAMA VE EĞİTİM MERKEZİ’NE AİT MEME VE SERVİKS KANSERLERİNİ TARAMA PROGRAMI SONUÇLARI
Abstract
Meme ve serviks kanserleri kadınlarda sık görülen kanserler olup, Kanser Erken Teşhis, Tarama ve Eğitim Merkezi (KETEM)’de tarama programı kapsamındadır. Bu çalışmanın amacı, 2016 ve 2017 yıllarını kapsayan süreçte, meme ve serviks kanseri taraması amacıyla yapılan başvuruları, tetkikleri ve bu doğrultuda alınmış olan anamnez formlarını retrospektif olarak değerlendirmektir. Kesitsel, retrospektif olan bu çalışmada meme ve serviks kanseri taraması için 2016 ve 2017 yıllarında Elazığ KETEM’e yapılan 632 başvuru değerlendirilmiştir. Veriler SPSS 22.0 programıyla değerlendirilmiş, normal dağılım için Kolmogrov-Smirnov testi kullanılmıştır. İstatistiksel değerlendirmelerde Mann Whitney U ve ki-kare testleri kullanılmış, p<0,05 istatistiksel anlamlılık olarak kabul edilmiştir. 632 kadın katılımcının yaş medyanı 50 (min:40, maks:66) idi. 17 kişinin (%2,7) smear sonucunda servikal prekanseröz lezyon saptanmıştır. Mamografi sonucu BI-RADS 1, 2 ve 3 olan %42,6 (269 kişi)’dir. Yapılan ileri tetkikler ve biyopsi sonucu BI-RADS 4, 5 olan 25 kişinin yapılan biyopsi sonucu 17 (%2,7) kişide meme kanseri tespit edilmiştir. Tarama sonucu elde edilen sonuçlar kişilerin sosyo-demografik özellikleri ile ilişkili bulunmamıştır. Tarama testleri kanser erken teşhisinde önemli yere sahip olup erken teşhis mortalite ve morbiditeyi azaltmaktadır. Mamografi ve Pap smear testi ucuz, kolay uygulanabilir, kolay ulaşılabilir, toplum tarafından kabul edilebilir tarama testleridir. Bu tarama programlarının tanıtımı arttırılarak halk katılım için teşvik edilmelidir.
Keywords
References
- 1. Fahad Ullah M. Breast cancer: current perspectives on the disease status. Adv Exp Med Biol. 2019;1152:51-64.
- 2. Villarreal-Garza C, Aguila C, Magallanes-Hoyos MC, Mohar A, et al. Breast cancer in young women in Latin America: an unmet, growing burden. Oncologist. 2013;18(12):1298-306.
- 3. Coughlin SS. Epidemiology of breast cancer in women. Adv Exp Med Biol. 2019;1152:9-29.
- 4. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010. A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60:99-119.
- 5. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
- 6. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005;89(2):4-12.
- 7. Aydın F, Tuncer ZS. Servikovaginal sitoloji ile önemi belirlenemeyen atipik skuamöz hücreler (ASCUS) ve önemi belirlenemeyen atipik glandüler hücreler (AGUS) tanısı alan olguların değerlendirmesi. T Klin Jinekol Obst. 2002;12:148-54.
- 8. Thomas C, Apgar MD. The 2001 Bethesda system terminology. Journal of the J Am Aced of Fam Phy. 2003;68:1-9.
- 9. Smith JHF. Bethesda. Cytopathology. 2001;13:4-10.
- 10. Ulusal Serviks (Rahimağzı) Kanseri Tarama Standartları. Available from: https://elazigism.saglik.gov.tr/TR,27216/ketem.html. ET: 24.05.2021.
- 11. American College of Radiology (ACR). Breast Imaging Reporting and Data System (BI–RADS). 4th ed. Reston: American College of Radiology. 2003:135-8.
- 12. D’Orsi CJ, Newell MS. BI–RADS decoded: detailed guidance on potentially confusing issues. Radiol Clin North Am. 2007;45(5):751–63.
- 13. Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda System terminology. Am Fam Physician. 2003;68(10):1992-8.
- 14. Berek JS. Simplification of the new Bethesda 2001 classification system. Am J Obstet Gynecol. 2003;188(3):2-5.
- 15. Astım, E. Cost-Effectiveness analysis of a prospective breast cancer screening program in Turkey. In partial fulfıllment of the requirements for the degree of master of science in economics in the department of economics. METU. January 2011:63-8.
- 16. Taş, ME (editör). Kanser Erken Tanısı ve KETEM Projesi Sonuç Raporu. Burak Ofset. 2012: 25-33.
- 17. Derici H, Tansuğ T, Nazlı O, Bozdağ AD, Koç O, Varer M, Yiğit S. Nonpalpabl meme lezyonlarının stereotaktik işaretlenmesi ve cerrahi eksizyonu. Meme Sağlığı Dergisi. 2007;3(1):10-13.
- 18. Anderson BO, Yip CH, Ramsey SD, Bengoa R, Braun S, Fitch M, et al. Breast cancer in limited-resource countries: health care systems and public policy. The Breast Journal. 2006;12(1): 54-69.
- 19. Parkin DM, Fernandez LMG. Use of statistics to assess the global burden of breast cancer. The Breast Journal. 2006;12(1):70-80.
- 20. Şahin S. Kanserde erken tanı ve tarama programları. Ege Tıp Dergisi. 2015;54(EkSayı):41-5.
- 21. Smith RA, Caleffi M, Albert US, Chen TH, Duffy SW, Franceschi D, et al. Breast cancer in limited-resource countries: Early detection and ccess to care. The Breast Journal. 2006;12(1):16-26.
- 22. Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A, et al. Guideline implementation for breast healthcare in lowincome and middle-income countries. Overview of the breast health global initiative global summit 2007. Cancer Supplement. 2008;113(8):2221-43.
- 23. Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiology. 2009;33:315-8.
- 24. Anderson BO, Braun S, Carlson RW, Gralow JR, Lagios MD, Lehman C, et al. Overview of breast health care guidelines for countries with limited resources. The Breast Journal. 2003;9(2):42-50.
- 25. Güner H. Jinekolojik Onkoloji Meme Hastalıkları. Güner H (Ed). 3. Basım. Çağdaş Medikal Kitapevi ve Yayıncılık Hizmetleri. Ankara. 2002:297-313.
- 26. Kurdoğlu Z, Kurdoğlu M, Kundakçı Gelir G, Keremoğlu Ö. Van Kanser Erken Teşhis, Tarama ve Eğitim Merkezi’ne ait serviks ve meme kanserlerini tarama programı sonuçları. Van Tıp Dergisi. 2009;16(4):119-23.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Public Health, Environmental Health |
| Journal Section | Research Article |
| Authors | |
| Publication Date | May 30, 2021 |
| Submission Date | February 26, 2021 |
| Published in Issue | Year 2021 Volume: 6 Issue: 2 |
Cited By
KADINLARIN HPV TESTİ YAPTIRMA NİYETLERİ VE İLİŞKİLİ FAKTÖRLER
Turkish Journal of Family Medicine and Primary Care
https://doi.org/10.21763/tjfmpc.1355017
International Peer Reviewed Journal
The journal adopts Open Access Policy and does not request article proccessing charge (APC), article publishing charge or any other charges.
This work is licensed under a Creative Commons Attribution 4.0 License